TURP和TPKEP对良性前列腺增生症近远期疗效的影响Short Term and Long Term Efficacy of TURP and TPKEP Treatment on Benign Prostatic Hyperplasia
陈江平
CHEN Jiangping
摘要(Abstract):
目的:探讨经尿道前列腺电切术(TURP)与经尿道前列腺等离子剜除术(TPKEP)治疗良性前列腺增生症(BPH)近远期疗效的影响。方法:124例BPH患者,根据手术方式的分为对照组(60例,行TURP)和TPKEP组(64例,行TPKEP),记录两组患者手术时间、切除前列腺质量、术中出血量、膀胱冲洗时间、留置导尿管时间及术后住院时间,分别于手术前及术后6月时进行IPSS评分、残余尿流量(RUV)、QOL评分及最大尿流率(Qmax),评价远期疗效;比较两组患者术中并发症、术后近期及远期并发症。结果:TPKEP组术中出血量、手术时间、冲洗膀胱时间、留置导尿管时间及术后住院时间短于对照组(P<0.05),而切除前列腺质量大于对照组(P<0.05);两组术后6月时IPSS、RUV及QOL评分低于治疗前,Qmax高于治疗前(P<0.05);两组术后6月时IPSS评分、RUV、QOL评分及Qmax比较,差异无统计学意义(P>0.05);TPKEP组术中并发症、术后早期并发症总发生率显著低于对照组(P<0.05),而远期并发症总发生率比较,差异无统计学意义(P>0.05)。结论:TPKEP治疗BPH效果优于TURP。
Objective: To investigate the short term and long term efficacy of transurethral resection( TURP) and transurethral plasma enucleation( TPKEP) treatments for benign prostatic hyperplasia.Methods: A total of 124 BPH patients were divided into TURP group( n = 62) and TPKEP group( n= 62). Operation time,prostate mass of resection,peroperative bleeding,bladder washing time,urinary catheter remaining time and hospitalization time were all recorded. IPSS evaluation,RUV,QOL evaluation and Qmax were performed before surgery and 6 months after operation to assess long term efficacy. Comparing intraoperative complications,postoperative short term and long term complications.Results: Intraoperative blood loss,operative time,bladder irrigation time,catheterization time and mean postoperative hospital stay of TPKEP group were shorter than TURP group( P < 0. 05),while the prostatectomy mass was greater than TURP group( P < 0. 05). The evaluation of international prostate symptom score( IPSS),residual urine flow( RUV) and quality of life( QOL) score 6 months later of both groups were lower than before treatment,and maximum urinary flow rate( Qmax) was higher than before treatment( P < 0. 05). The IPSS,RUV,QOL evaluation of both groups after 6 months compared with Qmax showed no statistical significance( P > 0. 05). The rates of intraoperative complications,the overall incidence of early postoperative complications of TPKEP group were significantly lower than TURP group( P < 0. 05),while long- term complications of both groups were no significant difference in the overall incidence( P > 0. 05). Conclusion: TPKEP treatment presents better efficacy than TURP.
关键词(KeyWords):
经尿道前列腺电切术;经尿道前列腺等离子剜除术;前列腺增生,良性;治疗结果
transurethral resection;transurethral plasma enucleation;prostatic hyperplasia,benign;curative results and long term efficacy
基金项目(Foundation):
作者(Author):
陈江平
CHEN Jiangping
DOI: 10.19367/j.cnki.1000-2707.2016.04.035
参考文献(References):
- [1]陈斌,郑嘉欣,张开颜,等.经尿道前列腺剜除术与电切术治疗不同质量良性前列腺增生的前瞻性研究[J].中华泌尿外科杂志,2013(8):608-612.
- [2]罗文清,王明,苟欣,等.经尿道前列腺剜除术与电切术治疗高危良性前列腺增生的安全性和疗效比较[J].重庆医科大学学报,2011(12):1524-1527.
- [3]Ran L,He W,Zhu X,et al.Comparison of fluid absorption between transurethral enucleation and transurethral resection for benign prostate hyperplasia[J].Urol Int,2013(1):26-30.
- [4]Xie L,Mao Q,Chen H,et al.Transurethral vapor enucleation and resection of the prostate with plasma vaporization button electrode for the treatment of benign prostatic hyperplasia:a feasibility study[J].J Endourol,2012(10):1264-1266.
- [5]潘铁军,魏世平,文瀚东,等.经尿道等离子前列腺剜除术和前列腺电切术的疗效比较[J].中华男科学杂志,2012(2):179-181.
- [6]卓栋,敖平,姜书传,等.经尿道前列腺等离子剜除术临床应用研究[J].安徽医学,2012(12):1601-1603.
- [7]李胜,曾宪涛,郭毅,等.经尿道等离子腔内剜除术与经尿道等离子双极电切术比较治疗良性前列腺增生的Meta分析[J].中国循证医学杂志,2011(10):1172-1183.
- [8]Geavlete B,Stanescu F,Iacoboaie C,et al.Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases-a medium term,prospective,randomized comparison[J].BJU Int,2013(5):793-803.
- [9]Geavlete BI,Mul爫escu R,Moldoveanu C,et al.Innovative technique in large benign prostatic hyperplasia-enucleation by plasma vaporization[J].Chirurgia(Bucur),2012(1):89-94.
- [10]张昊,张庄文,莫正雄,等.经尿道等离子前列腺剜除术治疗前列腺增生症的初步报告[J].中华全科医学,2011(11):1704-1705.
- [11]许凯,刘春晓.经尿道双极等离子体前列腺剜除术治疗良性前列腺增生症1 100例[J].实用医学杂志,2012(14):2395-2397.
- [12]Liao N,Yu J.A study comparing plasmakinetic enucleation with bipolar plasmakinetic resection of the prostate for benign prostatic hyperplasia[J].J Endourol,2012(7):884-888.
文章评论(Comment):
|
||||||||||||||||||
|